Shinderman M - Search Results

1

Alcohol and cocaine use and abuse among opioid addicts engaged in a methadone maintenance treatment program.

Maremmani I, Pani PP, Mellini A, Pacini M, Marini G, Lovrecic M, Perugi G, Shinderman M. Maremmani I, et al. Among authors: shinderman m. J Addict Dis. 2007;26(1):61-70. doi: 10.1300/J069v26n01_08. J Addict Dis. 2007. PMID: 17439869

2

Methadone dose and retention during treatment of heroin addicts with Axis I psychiatric comorbidity.

Maremmani I, Zolesi O, Aglietti M, Marini G, Tagliamonte A, Shinderman M, Maxwell S. Maremmani I, et al. Among authors: shinderman m. J Addict Dis. 2000;19(2):29-41. doi: 10.1300/J069v19n02_03. J Addict Dis. 2000. PMID: 10809518

3

Long-term outcomes of treatment-resistant heroin addicts with and without DSM-IV axis I psychiatric comorbidity (dual diagnosis).

Maremmani I, Pacini M, Lubrano S, Perugi G, Tagliamonte A, Pani PP, Gerra G, Shinderman M. Maremmani I, et al. Among authors: shinderman m. Eur Addict Res. 2008;14(3):134-42. doi: 10.1159/000130417. Epub 2008 Jun 13. Eur Addict Res. 2008. PMID: 18552489

4

Optimizing long-term response to methadone maintenance treatment: a 152-week follow-up using higher-dose methadone.

Maxwell S, Shinderman MS. Maxwell S, et al. Among authors: shinderman ms. J Addict Dis. 2002;21(3):1-12. doi: 10.1300/J069v21n03_01. J Addict Dis. 2002. PMID: 12094996

5

Use of naltrexone in the treatment of alcohol use disorders in patients with concomitant major mental illness.

Maxwell S, Shinderman MS. Maxwell S, et al. Among authors: shinderman ms. J Addict Dis. 2000;19(3):61-9. doi: 10.1300/J069v19n03_05. J Addict Dis. 2000. PMID: 11076120

6

Optimizing response to methadone maintenance treatment: use of higher-dose methadone.

Maxwell S, Shinderman M. Maxwell S, et al. Among authors: shinderman m. J Psychoactive Drugs. 1999 Apr-Jun;31(2):95-102. doi: 10.1080/02791072.1999.10471730. J Psychoactive Drugs. 1999. PMID: 10437990 Clinical Trial.

7

Cytochrome P4503A4 metabolic activity, methadone blood concentrations, and methadone doses.

Shinderman M, Maxwell S, Brawand-Amey M, Golay KP, Baumann P, Eap CB. Shinderman M, et al. Drug Alcohol Depend. 2003 Mar 1;69(2):205-11. doi: 10.1016/s0376-8716(02)00320-4. Drug Alcohol Depend. 2003. PMID: 12609702

8

When "enough" is not enough: new perspectives on optimal methadone maintenance dose.

Leavitt SB, Shinderman M, Maxwell S, Eap CB, Paris P. Leavitt SB, et al. Among authors: shinderman m. Mt Sinai J Med. 2000 Oct-Nov;67(5-6):404-11. Mt Sinai J Med. 2000. PMID: 11064491 Review.

9

An agency-based representative payee program and improved community tenure of persons with mental illness.

Luchins DJ, Hanrahan P, Conrad KJ, Savage C, Matters MD, Shinderman M. Luchins DJ, et al. Among authors: shinderman m. Psychiatr Serv. 1998 Sep;49(9):1218-22. doi: 10.1176/ps.49.9.1218. Psychiatr Serv. 1998. PMID: 9735966

10

Naltrexone for alcohol dependence.

Sinclair JD, Alho H, Shinderman M. Sinclair JD, et al. Among authors: shinderman m. N Engl J Med. 2002 Apr 25;346(17):1329-31; author reply 1329-31. N Engl J Med. 2002. PMID: 11973854 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

13 results

Search Page

Filters